Latest Breaking News On - Survival reported - Page 1 : comparemela.com

Advanced liver cancer patient in prior Phase II study remains cancer-free 6.9 years after starting treatment with Namodenoson .

United statesMotti farbsteinAmerican society of clinical oncologyClinical development milestonesUniversity of naples federicoCollaborations pharmaceuticalsFite biopharma ltdDrug administrationTelethon institute of geneticsAmerican association of cancer researchCan fite biopharmaDrug candidateSurvival reportedAdvanced liver cancer treatedAmerican societyClinical oncology